Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1150324

registered interest
date	17/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Disability
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the risks posed to people living with disabilities by a lack of availability of (a) medicines and (b) essential medical equipment in the event of the UK leaving the EU without a withdrawal agreement.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	1607
answer	answer is ministerial correction date of answer 22/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products once we have left the EU.</p><p>The Department, as part of our EU exit preparations, has analysed the supply chains of over 12,000 licensed medicines used by patients in the United Kingdom and close to half a million product lines of medical devices and clinical consumables with an EU/European Economic Area touchpoint. This approach means that the medicines and medical equipment used by people living with disabilities are included within our planning.</p><p>We continue to implement a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 22/10/2019 15:31:09 answering member 4362 label Biography information for Edward Argar
tabling member	1439 label Biography information for Norman Lamb

1150353

registered interest
date	17/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hearing Impairment: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether audiology Departments are required to collect data on the number of children identified as having hearing loss.
tabling member constituency	South Holland and The Deepings
tabling member printed	Sir John Hayes
uin	1546
answer	answer is ministerial correction date of answer 24/10/2019 answer text <p>All paediatric audiology services are required to record paediatric screening, assessment data, diagnosis and treatment data onto the national online database called ‘Smart for hearing’. This is co-ordinated centrally by the Newborn Hearing Screening team in the National Screening Office at Public Health England.</p><p> </p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 24/10/2019 11:46:52 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	350 label Biography information for Sir John Hayes

1150373

registered interest
date	17/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sugar: Consumption
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has on the impact of the sugar tax on trends in the level of sugar consumption.
tabling member constituency	Haltemprice and Howden
tabling member printed	Mr David Davis
uin	1558
answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>Public Health England has not made an assessment of the effect of the Soft Drinks Industry Levy (SDIL) on the level of sugar consumption.</p><p>The National Diet and Nutrition Survey is used to monitor trends in consumption of sugary soft drinks and sugar intakes. Data covering the period when the SDIL was introduced will be published in 2020.</p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 25/10/2019 13:02:17 answering member 4380 label Biography information for Jo Churchill
tabling member	373 label Biography information for Sir David Davis

1150375

registered interest
date	17/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fast Food: Health Hazards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect on public health of the availability of convenience food products.
tabling member constituency	Haltemprice and Howden
tabling member printed	Mr David Davis
uin	1560
answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>The childhood obesity plan recognises that convenience food products high in fat, salt or sugar can lead to weight gain, which in turn increases the risk of heart disease, type 2 diabetes, stroke and some cancers. High levels of sugar intake also increase the risk of tooth decay.</p><p> </p><p>Many of the measures in the three chapters of our childhood obesity plan will have an impact on improving diet and reducing obesity across all age groups. These include the soft drinks industry levy, sugar reduction and wider calorie reformulation programme, restricting promotions and calorie labelling in restaurants which will improve our eating habits and reduce the amount of sugar we consume.</p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 25/10/2019 13:03:14 answering member 4380 label Biography information for Jo Churchill
tabling member	373 label Biography information for Sir David Davis

1150376

registered interest
date	17/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Genomics: Data Protection
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the security of personal data created by genomic sequencing.
tabling member constituency	Haltemprice and Howden
tabling member printed	Mr David Davis
uin	1561
answer	answer is ministerial correction date of answer 24/10/2019 answer text <p>The National Health Service is working with Genomics England to ensure the security of personal data created by genomic sequencing through the new pipeline for Whole Genome Sequencing in the NHS.</p><p><strong> </strong></p><p>Genomics England has adopted a multi-layered approach to delivering cyber security and data protection for data generated from sequencing. The approach ensures that Genomics England data capture systems remain secure and are appropriately protected from external threats. Genomics England has engaged with the Department, NHS Digital and the National Cyber Security Centre to review the Genomics England Security Strategy and Policy and is working towards formal Cyber Security Accreditation during 2020.</p><p><strong> </strong></p><p>In April 2018, the Department launched the Data Security and Protection Toolkit. This covers the key data security and data protection requirements for health and social care organisations. Organisations can self-assess against it to demonstrate that they are meeting information governance requirements.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 24/10/2019 15:10:12 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	373 label Biography information for Sir David Davis

1150386

registered interest
date	17/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle (a) declining rates of childhood vaccination and (b) anti-vaccine misinformation.
tabling member constituency	Cities of London and Westminster
tabling member printed	Mark Field
uin	1599
answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>The Department is working with Public Health England (PHE), NHS England and NHS Improvement and other stakeholders to deliver a comprehensive vaccine and immunisation strategy this autumn. The strategy will set out a clear vision for maintaining and developing England’s world-leading immunisation programme over the next 10 years and beyond.</p><p>Actions planned or underway to increase the uptake of childhood vaccination include:</p><p>- Strengthening the role of local immunisation coordinators – healthcare professionals that promote vaccine uptake, particularly in under-served groups, by supporting areas with low uptake and tailoring specific local interventions to under-vaccinated communities;</p><p>- Updating NHS.uk to ensure availability of National Health Service-approved, evidence-based and trusted advice on vaccines; and</p><p>- A review of general practitioner vaccinations and immunisation standards, funding, and procurement to incentivise improved immunisation coverage.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 25/10/2019 12:55:10 answering member 4380 label Biography information for Jo Churchill
tabling member	1405 label Biography information for Mark Field

1150388

registered interest
date	17/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Blood: Contamination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, for what reasons parents and children of people who have died after being infected by contaminated blood products do not receive on-going financial support.
tabling member constituency	Leigh
tabling member printed	Jo Platt
uin	1790
answer	answer is ministerial correction date of answer 24/10/2019 answer text <p>The England Infected Blood Support Scheme (EIBSS) currently makes provision for <em>ex gratia</em> one-off payments to eligible spouses, civil partners and long-term partners for individuals meeting qualifying criteria.</p><p> </p><p>The EIBSS also makes provision to help with the costs of bringing up children of an infected beneficiary in the form of an income top-up payment. This is a discretionary monthly payment to increase household income to help with general living costs. These are means-tested payments for dependants who are defined as children of an infected beneficiary up to the age of 18 years, or up to 21 if in full-time education.</p><p> </p><p>In July 2017 the then Prime Minister announced the establishment of the Infected Blood Enquiry. This statutory inquiry chaired by Sir Brian Langstaff, will examine why men, women and children in the United Kingdom were given infected blood and/or infected blood products and the impact on their families. The Inquiry will consider the nature and the adequacy of the treatment, care and support (including financial assistance) and the Government will carefully consider any recommendations made.</p><p> </p><p> </p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 24/10/2019 15:47:42 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4673 label Biography information for Jo Platt

1150408

registered interest
date	17/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Epilepsy: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure people living in the London Borough of Southwark with epilepsy can continue to get the medication they need in the event of the UK leaving the EU without a deal.
tabling member constituency	Camberwell and Peckham
tabling member printed	Ms Harriet Harman
uin	1533
answer	answer is ministerial correction date of answer 22/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients throughout the United Kingdom that our plans should ensure the uninterrupted supply of medicines and medical products, including those for use in the treatment of epilepsy, once we have left the EU.</p><p>The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>We have been working closely with suppliers to monitor over 300 different epilepsy medicines provided by almost 50 companies and we are pleased to see many are holding stockpiles far beyond the six weeks’ additional buffer we requested. We also know that the vast majority of those suppliers with lower levels of stockpiles have already taken action to re-route their supply chains away from the Channel short straits crossings where applicable.</p><p> </p><p>The Department, alongside NHS England and NHS Improvement, is ensuring that there is regular communication with frontline NHS organisations and stakeholders in the health and social care sector regarding our EU exit preparations. NHS England and NHS Improvement have also been holding EU exit roadshows in the lead up to 31 October.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 22/10/2019 11:18:05 answering member 4362 label Biography information for Edward Argar
tabling member	150 label Biography information for Ms Harriet Harman

1150410

registered interest
date	17/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will commit to commencing routine commissioning of PrEP from April 2020.
tabling member constituency	Brighton, Kemptown
tabling member printed	Lloyd Russell-Moyle
uin	1767
answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>Pre-exposure prophylaxis (PrEP) is currently provided in England through the three year PrEP Impact Trial. Participation in the trial is on a voluntary basis and it is for clinics and local authorities to decide the number of allocated places they can accept.</p><p>The Department is continuing to work closely with NHS England and NHS Improvement, Public Health England and local authorities to plan for a seamless transition from the PrEP Impact Trial to routine commissioning from April 2020.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 1768 question first answered 25/10/2019 13:08:36 answering member 4380 label Biography information for Jo Churchill
tabling member	4615 label Biography information for Lloyd Russell-Moyle

1150411

registered interest
date	17/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress is being made towards the routine commissioning of PrEP.
tabling member constituency	Brighton, Kemptown
tabling member printed	Lloyd Russell-Moyle
uin	1768
answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>Pre-exposure prophylaxis (PrEP) is currently provided in England through the three year PrEP Impact Trial. Participation in the trial is on a voluntary basis and it is for clinics and local authorities to decide the number of allocated places they can accept.</p><p>The Department is continuing to work closely with NHS England and NHS Improvement, Public Health England and local authorities to plan for a seamless transition from the PrEP Impact Trial to routine commissioning from April 2020.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 1767 question first answered 25/10/2019 13:08:36 answering member 4380 label Biography information for Jo Churchill
tabling member	4615 label Biography information for Lloyd Russell-Moyle